AROC in Pharmaceutical and Biotechnology
ISSN: 2789-3928
Menu
Journal Menu
Recent Journals
AROC in Pharmaceutical and Biotechnology
- Volume 1 Issue 1
AROC in Pharmaceutical and Biotechnology, 2021,1(1);34-43
- August 3, 2021
- Keywords: Coagulase-negative staphylococci (CoNS); methicillin-resistant – coagulase-negative Staphylococci (MRCoNS); multiple antibiotic resistance index (MARI); antimicrobial agents pages
- Author(s): Cecilia T. Atolagbe, Babajide A. Tytler, Olanrewaju Jimoh, Adebola T. Olayinka, and Busayo O. Olayinka
- Volume 1 Issue 1
AROC in Pharmaceutical and Biotechnology, 2021,1(1);26-33
- July 22, 2021
- Keywords: Domestic waste, Partial characterization, protease Pseudomonas aeruginosa and Bacillus subtilis pages
- Author(s): Tsado A. Ndarubu, Jiya A. Gboke, Ibrahim A. Habiba, Gana David, Zubairu Rakiya, Danazumi Nathaniel, Mohammed A. Saba, Aliyu Muhammad, and Akinniran C. Sunday
- Volume 1 Issue 1
AROC in Pharmaceutical and Biotechnology, 2021,1(1);17-25
- June 29, 2021
- Keywords: Herbicide; Bacteria and Fungi Isolate; Farmland; Keffi, Nasarawa State; Nigeria pages
- Author(s): Makwin Danladi Makut and Murtala Zaharadeen Ibrahim
- Volume 1 Issue 1
AROC in Pharmaceutical and Biotechnology, 2021,1(1);09-16
- June 9, 2021
- Keywords: Staphylococcus aureus; prevalence; dogs; pigs; handlers; Zaria and Kaduna pages
- Author(s): Oyeronke Olamide Okeniyi, Josiah Ademola Onaolapo, and Rebecca Olajumoke Bolaji
- Volume 1 Issue 1
AROC in Pharmaceutical and Biotechnology, 2021,1(1);01-08
- May 24, 2021
- Keywords: Azadirachtin-A; Azadiracta indica; SARS-CoV-2 main protease; molecular docking pages
- Author(s): Dauda Muhammed, Bernard O. Odey, Blessing U. Alozieuwa, Rahmatallah A. Alawode, Banke M. Okunlola, Jonathan Ibrahim, Abdullateef Lawal, and Eustace B. Berinyuy
Search Journal
Email Alert
Enter your email to receive all forthcoming issues from this Journal
Call for Graphical Abstract Contest
Design a graphical abstract and stand a chance to win $500
Submit Your Article
Twitter Feed
Twitter feed is not available at the moment.
